Loading…
Stevanato Group's subsidiary OMPI of America agreed with BARDA, a US government agency, to receive up to about $95 million to expand planned vial manufacturing capacity in Fishers, Indiana. The aim is to strengthen US national defense and public health readiness.
High Purity New England received a $15 million contract from BARDA to expand production of single-use biopharma consumables, funding a fourth facility in Smithfield, Rhode Island.